1 enrolling by invitation, 1 not yet recruiting, 1 recruiting. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1 |
Follow ALPFA Medical: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Establish the Safety and Effectiveness of the ALPFA GRAIL PFA System for Treating Symptomatic Benign Prostate Hyperplasia (BPH) Also Known as an Enlarged Prostate. Treatment Device: The ALPFA Medical (ALPFA) GRAIL™ Pulsed Field Ablation (PFA) System, Control Device: Sham flexible cystoscopy - Benign Prostatic Hyperplasia (BPH) | Not applicable | Recruiting | ALPFA Medical | 250 | 2026-10-01 | 2026-10-20 |
| A Prospective, Single-Arm, Pilot Study of the ALPFA BPH PFA System in Men With Low, Intermediate and High-Risk Prostate Cancer ALPFA BPH PFA System - Prostate Cancer | Not applicable | Not yet recruiting | ALPFA Medical | 50 | 2026-04-01 | 2026-04-07 |
| A Pilot Study Of The ALPFA Benign Prostatic Hyperplasia (BPH) Pulsed Field Ablation (PFA) System ALPFA BPH PFA System - Benign Prostatic Hyperplasia | Not applicable | Enrolling by invitation | ALPFA Medical | 100 | 2025-02-07 | 2026-06-25 |
Prostatic Hyperplasia (2) · Prostatic Neoplasms (1)
Czechia (1) · Italy (1) · Panama (1) · United States (1)
Dr. Bilal Chughtai (1) · Dr. Dean Elterman (1)